News Industry News FDA approves wearable defibrillator for children at risk for sudden cardiac arrest December 17, 2015
News Daily News Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee Michael O'Riordan December 15, 2015
News Daily News Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV Michael O'Riordan December 15, 2015
News Daily News ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention Michael O'Riordan December 13, 2015
News Daily News NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication Michael O'Riordan December 08, 2015
News Daily News Sugary Drinks an Increasing Threat to Global Cardiometabolic Health Todd Neale December 02, 2015
News Daily News Las Bebidas Azucaradas son una Amenaza contra la Salud Cardiometabólica Global Todd Neale December 02, 2015
News Daily News Observational Study Hints at Real Benefits for Patients Who Take PUFAs After Acute MI November 30, 2015
News Daily News Un Estudio Observacional Revela los Beneficios Reales de Pacientes a Tratamiento con AGPI Post-IAM November 30, 2015
News Conference News AHA 2015 PROMISE Analyses: Coronary CTA May Hold Some Benefits for Patients With Suspected CAD Todd Neale November 10, 2015
News Conference News AHA 2015 Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower Yael L. Maxwell November 08, 2015
News Conference News AHA 2015 AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More Shelley Wood November 05, 2015
News Daily News La Puerta se Cierra para las Dietas Bajas en Grasas en lo que al Manejo del Peso a Largo Plazo se refiere Todd Neale November 01, 2015
News Daily News Door Closing on Low-fat Diets for Long-term Weight Management Todd Neale November 01, 2015
Presentation Effect of Low-fat vs Other Diet Interventions on Long-term Weight Change in Adults Presenter: Deirdre Tobias October 30, 2015
News Industry News FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa October 20, 2015
News Conference News TCT 2015 Keynote: Simplified Trials, Community Engagement Key to Reinvention of Clinical Research October 13, 2015
News Industry News Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union September 28, 2015